Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods

Neurobasal medium

Manufactured by Thermo Fisher Scientific
Sourced in United States, Germany, United Kingdom, Japan, Canada, France, Italy, Switzerland, Spain, Australia, China, Sweden, Austria, Belgium, New Zealand, Ireland, Netherlands, Israel, Macao, Poland, Denmark, Argentina, Portugal
About the product

Neurobasal medium is a cell culture medium designed for the maintenance and growth of primary neuronal cells. It provides a defined, serum-free environment that supports the survival and differentiation of neurons. The medium is optimized to maintain the phenotypic characteristics of neurons and minimizes the growth of non-neuronal cells.

Automatically generated - may contain errors

6 800 protocols using neurobasal medium

1

Isolation and Culture of Primary Neuronal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The prefrontal cortex tissues were digested according to a previously described method90 (link) with some minor modifications. Briefly, the prefrontal cortex tissues from human PCW9 and macaque E51 fetal brains were transferred into a new sterile 3.5-cm dish with 100 µL fresh sterile ice-cold HBSS++ buffer. After discarding the HBSS++ buffer, the tissues were sliced into sizes less than 1 mm3 using a sterile surgical blade. Immediately, the minced prefrontal cortex tissues were digested in a 15-mL tube with 2 mL of 20-unit/mL papain (Worthington, Lakewood, NJ, USA, Cat. No. LK003178) and 200 µL 200-Knuitz-units/mL DNase I (Worthington, Cat. No. LK003172), both of which were dissolved in HBSS with Ca2+ and Mg2+ (Thermo Fisher Scientific, Cat. No. 14025092). The tube was then rotated 30 rounds per minute (rpm) at 30 °C for 30 minutes (min).
After incubation, the tube was centrifuged at 150 × g for 1 min at room temperature (RT), and the supernatant was removed as much as possible with a P1000 pipette. The tissue/cell pellet was suspended using 2 mL RT Neurobasal++ medium, containing Neurobasal medium (Thermo Fisher Scientific, Cat. No. 21103049) supplemented with 1× B27 (Thermo Fisher Scientific, Cat. No. 17504044) and 1× GlutaMAX (Thermo Fisher Scientific, Cat. No. 35050-061). Single cells were released by triturating the tissue/pellet by pipetting up and down ten times with 1-mL LoBind tip (Thermo Fisher Scientific, Cat. No. TFLR1121000-Q) in 45 s without introducing bubbles. The tube was settled for 1 min, and the supernatant containing the released single cells was transferred to a new 15-mL tube without disturbing the remaining tissues at the tube bottom. Another 2 mL Neurobasal++ was added into the tube with the remaining tissues. The trituration, as described above, was repeated two more times to achieve maximum single-cell release. The supernatant containing the released single cells was combined and centrifuged at 800 × g for 5 min at RT. After discarding the supernatant fraction, 6 mL complete medium, which was comprised of Neurobasal medium supplemented with 1× B27, 1× GlutaMAX, 1× penicillin/streptomycin, and 5 ng/mL human FGF2 (Novoprotein, Wuhan, China, Cat. No. GMP-C046), was added to resuspend the pelleted cells. An aliquot of 10 µL cell suspension was used to assess the cell viability. Usually, the isolated cells showed a cell viability of more than 98%.
Next, the isolated single cells were seeded in the 6-well plate wells that were pre-coated with 0.1 mg/mL Poly-D-Lys (Sigma-Aldrich, St. Louis, MO, USA, Cat. No. P6407) dissolved in sterile miliQ water. Each well was seeded with 1.2 million cells and added with 2 mL of complete medium. For culturing the primary neuronal cells that were used for immunostaining, ~10,000 cells were seeded into each well of the 24-well plate with a 12-mm coverslip (Electron Microscopy Science, Hatfield, PA, USA, Cat. No. 72196-12) pre-coated with Poly-D-Lys. The seeded cells were maintained in a 37 °C incubator with 5% CO2 by half medium exchange every 2 days since day 5 after seeding cells. The primary neuronal cells were collected on day 20 and day 15 for human and macaque cells, respectively. Those primary neuronal cells were applied for subsequential experiments.
+ Open protocol
+ Expand
2

Isolation and Culture of Hippocampal Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dissociated primary hippocampal neuron cultures were prepared as previously described24 (link). Briefly, 18.5-day old embryos were collected from timed-pregnant Sprague Dawley rats (Charles River Laboratories), and then hippocampi were dissected in ice-cold Hank’s Balanced Salt Solution (HBSS). Hippocampi were pooled together, trypsinized for 12 minutes (mins.), briefly incubated in 20% fetal bovine serum (Atlanta Biologicals, #S11150) and then plated on 25 mm coverslips coated with 100 μg/ml poly-L-lysine (P2636; Sigma-Aldrich) at two different densities, ~150,000 or 25,000 cells per 35 mm dish for two different treatment conditions (see below). Hippocampal neurons were cultured in Neurobasal medium (21103049; Gibco) supplemented with 1% B-27 (17504044; Gibco), 1% Penicillin/Streptomycin (30002CI; ThermoFisher), and 1% GlutaMax (35050061; Gibco). The culture medium was replaced with fresh medium 24 hours (hrs.) after plating. Animal care and use was conducted following National Institutes of Health guidelines, and procedures were approved by the Institutional Animal Care and Use Committee at Emory University.
Cath.-a-differentiated (CAD) cells25 (link) were used for analyses of fascin localization in lamellipodia and filopodia. CAD cells were cultured in DMEM/F12 (10–092-CV; Corning) media supplemented with 8% fetal bovine serum (Atlanta Biologicals, #S11150) and 1% Penicillin/Streptomycin (Invitrogen, #15140122). For imaging, we resuspended CAD cells by mechanical force and plated them on laminin-coated No. 1.5 glass coverslips for one hr. (laminin: CAS#: 114956-81-9, Millipore Sigma; 20 μg/mL for 1 hr. at 37 °C) before fixation and immunocytochemistry.
+ Open protocol
+ Expand
3

Culturing Primary Neurons from Mouse Embryos

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary neurons were obtained from the brains of C57BL/6J embryos at embryonic days 14–15, as reported previously (Grimm et al., 2018 (link); Guo et al., 2021 (link)). Briefly, embryos were collected, followed by the careful removal of the meninges and blood vessels under a microscope. The cerebral cortex was then shredded and digested with pancreatic enzymes for 10 min. Neurons were resuspended in Neurobasal medium (Gibco, 21103-49, USA) supplemented with 2% B-27 (Gibco, 17504-044, USA) and 1% L-glutamine (Gibco, 25030-081, USA). The neurons were cultured in a 5% CO2 incubator at 37°C for 7 days, with the culture medium renewed every 3 days.
+ Open protocol
+ Expand
4

Differentiation and Co-culture of Myotubes and Motor Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 15-mm round coverslip was placed in each well of a 24-well plate. Myogenic progenitor cells were seeded into the Geltrex-coated wells at a density of 250,000–300,000 cells per well (120,000–150,000 cells/cm2). MyoCult™ Differentiation Medium was added at 750 μL to each well, and the cultures were incubated for 5 days. Multinucleated myotubes gradually formed and their proportion increased over this period. On day 5, the differentiation medium was replaced with neurobasal medium (ThermoFisher Scientific) supplemented with 1% N2, 1 mM NEAAs, 2 mM glutamate, 2% B27, and 1% RevitaCell Supplement (ThermoFisher Scientific). Subsequently, MN spheres were thawed and suspended in a total of 5 mL of NB medium. The number of spheres in 1 mL cell suspension was counted, followed by centrifugation at 1000 rpm for 2 min. Fifty spheres were then dissociated using Accutase for 5 min, with gentle mechanical pipetting every minute with a P1000 pipetman to create cell clumps smaller than 100 μm, seeded onto the differentiated myotubes. The day after seeding the MN EBs, RevitaCell Supplement was replaced with 0.2 μM compound E (Cayman Chemical). The medium was changed every 2 days. The cells were cocultured for 4–7 days, after which the NMJs could be analyzed.
+ Open protocol
+ Expand
5

Differentiation of mESCs into Spinal MNs

Check if the same lab product or an alternative is used in the 5 most similar protocols
mESCs were cultured and differentiated into spinal MNs as described in Wichterle and Peljto (2008) (link), Capauto et al. (2018) (link), and D'Ambra et al. (2024) (link). Briefly, cells were maintained in culture with mESC medium, (EmbryoMax DMEM; 15% Embryonic stem-cell FBS, Thermo Fisher Scientific; 1% EmbryoMax 100X nucleosides, Sigma-Aldrich; 1% EmbryoMax nonessential amino acids, Sigma-Aldrich; 2-mercaptoethanol for ES cells, Sigma-Aldrich; 2 mM l-glutamine, Sigma-Aldrich; 1% penicillin-streptomycin, Sigma-Aldrich), supplemented with ESGRO Recombinant Mouse LIF Protein (Chemicon), FGFR inhibitor PD173074 (Sigma-Aldrich P2499), and GSK-3 Inhibitor XVI (Sigma-Aldrich 361559).
For motoneuronal differentiation, embryoid bodies (EBs) were obtained by culturing mESCs in ADNFK medium (1:1), Advanced DMEM/F12 (Gibco):Neurobasal medium (Gibco), 10% Knock Out Serum Replacement (Gibco), 1% GlutaMAX, 1% 2-mercaptoethanol, 1% Pen/Strep. After 2 days, ADNFK medium was supplemented with 2% B27 Supplement (Gibco), 1 μM RA (Sigma-Aldrich) and 0.5 μM SAG (Merck Millipore). On day 5, ADNFK medium was supplemented with 2% B27 Supplement and 5 ng/mL GDNF (PeproTech). On day 6, EBs were dissociated: first, EBs were incubated with 20 U/mL Papain (Worthington Biochemical Corporation), agitated for 5 min by hand, then blocked with 10 mg/mL ovomucoid inhibitor (Worthington Biochemical Corporation) for 5 min. Cells were then left to precipitate by gravity, and supernatant was removed. Single cells were then dissociated by pipetting in PBS supplemented with 0.4% Glucose (Sigma), 2.5% horse serum (Thermo Fisher Scientific), 2% B27, 3 mM MgCl2, Deoxyribonuclease I (Sigma-Aldrich, 25 μg/mL) and plated on 0.01% poly-l-ornithine (Sigma-Aldrich), Laminin 20 μg/mL (Sigma) coated glass coverslips. MNs were maintained in culture with N2B27 medium (50% DMEM/F-12 Ham, 50% Neurobasal medium, 1% GlutaMAX Supplement, 1% 2-mercaptoethanol, 1% nonessential amino acids, 0.5% penicillin-streptomycin) supplemented with 2% N-2 supplement (Gibco), 1% B-27 supplement serum free (Thermo Fisher Scientific), 200 ng/mL l-ascorbic acid (Sigma-Aldrich), 20 ng/mL BDNF (PeproTech), 10 ng/mL GDNF (PeproTech), 10 ng/mL CNTF (PeproTech) and 10 mM ROCK inhibitor (Y-27632 dihydrochloride; Sigma-Aldrich).
For experiments carried out in stress condition, NaAsO2 at a final concentration of 0.5 mM was added to the neuronal medium and incubated for 1 h.
+ Open protocol
+ Expand
6

Generating Oligodendrocytes from hiPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the current study, a hiPSC line (UKERiO3H-S1-006) was used that was generated from dermal fibroblasts of a 71-yr-old healthy male and genetically modified by integration of a Dox-inducible expression cassette for SOX10, OLIG2, and NKX6.2 (SON cassette) into the adeno-associated virus integration site 1. This cell line is referred to as SON15. Karyotyping revealed a balanced translocation between the Y chromosome and one chromosome 20. In most cells, an additional derivative chromosome 20 was present. In a small percentage of cells, an isochromosome 20q was detectable instead of the two derivative chromosomes 20. This kind of chromosomal alterations is frequent in pluripotent stem cells (Avery et al, 2013 (link)). SON15 hiPSCs were cultured on 6-well plates coated with Matrigel growth factor reduced (Thermo Fisher Scientific) in mTeSR Plus medium (StemCell Technologies) with penicillin–streptomycin (Anprotec). Medium change was performed daily, passaging once a week using ReLeSR (StemCell Technologies) according to the manufacturer’s instructions.
For the generation of hiPSC-derived NPCs, hiPSCs were cultured on a layer of mitomycin C–treated primary mouse embryonic fibroblasts in hES medium, consisting of DMEM/F12 + GlutaMAX (Thermo Fisher Scientific), 20% KnockOut Serum Replacement (Thermo Fisher Scientific), FGF2 (PeproTech), 1% penicillin–streptomycin, 1% nonessential amino acids (Thermo Fisher Scientific), and 0.05 mM 2-mercaptoethanol (Roth). After reaching 80% confluency, hiPSCs were detached with ReLeSR and expanded on Matrigel-coated dishes. For embryoid body (EB) formation, cells were transferred in ultra-low attachment dishes (Corning) and cultured in hES medium containing dorsomorphin (1 μM; Cell Guidance Systems), Chir99021 (3 μM; Cell Guidance Systems), and SB431542 (10 μM; PeproTech). On the second day, medium was changed to N2B27 medium composed of Neurobasal medium (Thermo Fisher Scientific), DMEM/F12 + GlutaMAX, 0.5 × N2 and 0.5 × B27 supplement w/o vitamin A (Thermo Fisher Scientific), dorsomorphin (1 μM), Chir99021 (3 μM), purmorphamine (0.5 μM; Tocris Bioscience), and SB431542 (10 μM). On day 4, dorsomorphin was replaced by ascorbic acid (150 mM; Sigma-Aldrich). On day 6 of differentiation, around 20–30 EB colonies were picked and transferred to a Matrigel-coated plate containing the same medium. EB colonies were dissociated and resulting cells plated. From passages 0–4, NPCs were split at a ratio of 1:2–1:6, and afterward at a higher ratio of 1:8–1:10. From passage 6 on, the ROCK inhibitor Y-27632 (RI, 2 μM; Selleck Chemicals) was added and purmorphamine was replaced by smoothened agonist (SAG, 0.5 μM; Cayman Chemicals) resulting in a medium referred to as N-SAG.
For oligodendrocyte differentiation, NPCs were used from passage 6 onward. Approximately 1 × 105 cells per well of a 12-well plate were seeded, and doxycycline (3 μg/ml; Sigma-Aldrich) was added to the medium for the induction of the SON cassette (day −2 of oligodendrocyte differentiation). On day 0 of differentiation, the medium was changed to glial induction medium consisting of DMEM/F12 + GlutaMAX, 1% penicillin–streptomycin, 0.5 × N2 and 0.5 × B27 supplement w/o vitamin A, 0.5 μM SAG, 10 ng/ml PDGF-AA (PeproTech), 10 ng/ml NT-3 (PeproTech), 10 ng/ml IGF-1 (R&D Systems), 10 ng/ml T3 (Sigma-Aldrich), 200 μM ascorbic acid, 0.1% Trace Element B (Corning), and 3 μg/ml doxycycline. On day 4 of differentiation, medium was changed to glial differentiation medium composed of DMEM/F12 + GlutaMAX, 1% penicillin–streptomycin, 0.5 × N2 supplement, 0.5 × B27 supplement w/o vitamin A, 10 ng/ml NT-3, 10 ng/ml IGF-1, 10 ng/ml T3, 200 μM ascorbic acid, 0.1% Trace Element B, 100 μM N6, 2’-O-dibutyryladenosine 3’: 5’-cyclic monophosphate sodium salt (dbcAMP; Sigma-Aldrich), and 3 μg/ml doxycycline. On day 7, cells were replated at a density of 1 × 105 cells per well of a 12-well plate, or at a density of 0.5 × 105 cells per well of a 24-well plate. On day 10, Dox was withdrawn. By day 18, the cells were terminally differentiated and analyzed by flow cytometry or immunocytochemistry (see below). All cells were regularly tested for the presence of Mycoplasma using PCR Mycoplasma Test Kit (PromoKine) or LookOut Mycoplasma PCR Detection Kit (Sigma-Aldrich).
+ Open protocol
+ Expand
7

Culturing HEK293 and Primary Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell line HEK293 was grown in DMEM (Gibco, Cat# 10313021) with 10% of calf serum (Cytiva, Cat# SH30087.03) and antibiotics (Sigma-Aldrich, Cat# A5955), at 37°C and 5% of CO2 in a humid atmosphere. Primary neuron cultures were obtained from E17–18 brain cortices dissected from wild-type (C57/Bl6) or tau knock-out mice (13 (link)), as previously described (14 (link)). Neuron cultures were grown in poly-D-lysine (Sigma, Cat# P0899) coated surfaces for 10–11 days in vitro in Neurobasal medium (Gibco, Cat# 21103049) supplemented with B-27 (Gibco, Cat# 17504044) and in the presence of 1.5 g/L of glucose (Sigma, Cat# 16301), 2 mM of GlutaMAX (Gibco, Cat# 35050061) and 10 μg/mL of gentamicin (Gibco, Cat# 15710064).
+ Open protocol
+ Expand
8

Efficient Reprogramming of hiPSCs via Episomal Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve resetting was performed as previously described (MacCarthy et al, 2024 (link)). Briefly:

3 μg of episomal pCXLE-Sox2A61V-2A-Klf4-2A-Myc (Addgene #210017) and 3 μg of pCXWB-EBNA1 (Addgene #37624) were co-nucleofected into 1 × 106 primed hiPSCs using the Lonza 4D-nucleofector (“Primary Cell P3” solution, “CM-113” program)

Cells were plated on a feeder layer of irradiated CF1 MEFs (Thermo Fisher, 4 × 106 MEFs per six- well plate) at 8 × 104 nucleofected cells per well, in StemFlex media supplemented with 10 µM Y-27632.

The next day, the medium was changed to PXL medium (described below).

The cells were fed daily.

At day 6, the cells were harvested using Accutase, and used for iOLC induction (without sorting).

Composition of PXL medium:

1:1 mix of Neurobasal medium (Gibco, 21103049) and Advanced DMEM/F12 (Gibco, 11320082) supplemented with:

1X N2 (Gibco, 17502048)

1X B27 minus vitamin A (Gibco, 12587010)

1X sodium pyruvate (Gibco, 11360070)

1X non-essential amino acids (Gibco, 11140050)

1X GlutaMAX (Gibco, 35050061)

1X Penicillin-Streptomycin (Gibco, 15070063)

0.1 mM b-mercaptoethanol (Gibco, 31350010, 1 ml in 500)

50 μg/ml l-ascorbic acid (Sigma, A8960)

0.2% Geltrex (Gibco, A1413301)

1 μM PD0325901

2 μM XAV939 (Sigma, X3004)

20 ng/ml hLIF (Peprotech, 300-05).

+ Open protocol
+ Expand
9

Differentiating Microglia-like Cells from hiPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To differentiate microglia-like cells from hiPSCs, both hiPSC-EGFP and hiPSCs-RFP were used following the protocol described previously [28 (link), 29 (link)]. Briefly, when iPSCs reached approximately 85% confluence in six-well plates, they were dissociated with 0.5mM EDTA solution (Nuwacell) and then cultured in suspension in advanced DMEM/F12 medium (Cat.# 12634010, Gibco, USA) supplemented with 10% KnockOut SR (Cat.#10828028, Gibco, USA), 2mM GlutaMAX (Cat.# 35050-061, Gibco), 100U/ml Pen/100µg/ml Strep (Cat.# 10378016, Gibco, USA), 0.1mM β-mercaptoethanol (Cat.# M6250, Sigma-Aldrich, USA) and 1.5 µg/ml blebbistatin (Nuwacell). On differentiation day 4, the embryoid bodies (EBs) were transferred to a 100 mm dish pre-coated with 0.1% gelatin (Cat.# es-006-B, Merck Sigma) using Lonza X-vivo 15 plus medium (Cat.# 04-418Q, Lonza, USA) supplemented with 2mM GlutaMAX, 100U/ml Pen/100µg/ml Strep, 0.1mM β-mercaptoethanol, 25ng/ml hrIL-3 (Cat.# 203-IL-050, R&D Systems, USA) and 50ng/ml hrM-CSF (Cat.# 216-MC-500, R&D Systems). The medium was then changed every 7 days. After approximately one month, hematopoietic progenitor cells were generated and suspended in the medium. The suspended cells were carefully collected and subjected to iMG differentiation in the medium consisting of DMEM/F12 (Cat.# 10565018, Gibco, USA) and neurobasal medium (Cat.# 21103049, Gibco, USA) containing 1% B27 supplement (Cat.# RC01026, Nuwacell), 0.5% N2 supplement (Cat.# 17502-048, Gibco, USA), 2mM GlutaMAX and 0.1mM β-mercaptoethanol, supplemented with 100ng/ml hrM-CSF (R&D Systems, USA) and100ng/ml hrIL-34 (Cat.# 200 − 34, PeproTech, USA).
+ Open protocol
+ Expand
10

Generation of Neural Spheroids from NSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved primitive NSCs were used for neural spheroid generation. Thawed NSCs were plated onto Geltrex-coated six-well plates in NSC expansion medium, with the medium refreshed every other day until the cells reached confluence. Neural spheroids were subsequently generated following a previously described protocol [8 (link),19 (link)], with modifications.
Confluent primitive NSCs were dissociated using Accutase and seeded at a density of 1 × 104 cells per well in low-adhesion V-bottom 96-well plates (Sumitomo Bakelite, Tokyo, Japan). The cells were cultured in neural spheroid medium, which comprised 47 % Neurobasal medium, 47 % Advanced DMEM/F12, 1 % N2 supplement, 2 % B27 supplement, 1 % Penicillin/Streptomycin, 1 % GlutaMax, 1 % nonessential amino acids, and 25 μM β-mercaptoethanol (all from Thermo Fisher Scientific).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.